Építés alatt – nem éles oldal
Belépés

Hasnyálmirigyrák trials, also abroad

1213 open Hasnyálmirigyrák trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

OrszágOpen trials
Egyesült Államok405
Kína326
Franciaország117
Olaszország93
Spanyolország86
All other countries

The same trial often runs in several countries

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma has 5 sites in Tajvan and runs in 22 countries. If a site near you is full, another one may still take people.

See Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma in all 22 countries
Építés alatt, nem éles – Hasnyálmirigyrák: vizsgálatok itt: Tajvan – Frontlight Research